Back

SGLT2 inhibitors: is the benefit related to renal outcomes?

2 September 2019 (17:15 - 17:32)
Organised by:
Congress Presentation Part of: SGLT2 inhibitors and cardiovascular outcomes Diabetes and the Heart ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Antonio Ceriello

IRCCS - MultiMedica, Milan (Italy)

3 More presentations in this session

Presentation thumbnail
SGLT2 inhibitors and atherosclerosis-related outcomes: the good and the bad
Professor A. Norhammar (Stockholm, SE)
Slides Video
Presentation thumbnail
SGLT2 inhibitors and heart failure: expensive diuretics or added value?
Doctor M. Kosiborod (Kansas City, US)
Slides Video
Presentation thumbnail
Panel discussion: how should cardiologists use SGLT2 inhibitors in clinical practice?
Video

Access the full session

Session thumbnail
SGLT2 inhibitors and cardiovascular outcomes

The Event

Event poster

ESC Congress 2019

2 September 2019 17:15 CET
You may be interested in
thumbnail
Webinar
Prevention of heart failure in diabetic patients at population level
thumbnail
Congress Session
Diabetes, obesity, and heart failure
thumbnail
Webinar
Diabetes and ACS - enhancing post-discharge outcomes after primary PCI

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources